Prevencio Email Format
Biotechnology ResearchWashington, United States11-50 Employees
The company has published in top-tier cardiology journals and presented findings at leading cardiovascular meetings, reflecting its established activity in the field. Recent developments include collaborations with Seattle Children's Hospital to study Kawasaki disease in children and with Massachusetts General Hospital on AI-enabled test development, along with a January 2026 integration of its HART tests into Quadrant Health's primary care model.